cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.26993338.v1
title: Additional file 4 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 4: Table S3. DEGs detected in bulk transcriptomics. Q175 vs WT comparison.
DOI: 10.6084/m9.figshare.26993341
title: Additional file 5 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 5: Table S4. GO terms from GSEA analysis performed in Q175 vs WT comparison.
DOI: 10.6084/m9.figshare.26993341.v1
title: Additional file 5 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 5: Table S4. GO terms from GSEA analysis performed in Q175 vs WT comparison.
DOI: 10.6084/m9.figshare.26993344
title: Additional file 6 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 6: Table S5. KEGG pathways from GSEA analysis performed by Agus et al., 2019 in symptomatic HD vs control BA9 samples.
DOI: 10.6084/m9.figshare.26993344.v1
title: Additional file 6 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 6: Table S5. KEGG pathways from GSEA analysis performed by Agus et al., 2019 in symptomatic HD vs control BA9 samples.
DOI: 10.6084/m9.figshare.26993347
title: Additional file 7 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 7: Table S6. All quantifiable protein groups.
DOI: 10.6084/m9.figshare.26993347.v1
title: Additional file 7 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 7: Table S6. All quantifiable protein groups.
DOI: 10.6084/m9.figshare.26993350
title: Additional file 8 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 8: Table S7. Consensus path analysis on proteomic data.
DOI: 10.6084/m9.figshare.26993350.v1
title: Additional file 8 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 8: Table S7. Consensus path analysis on proteomic data.
DOI: 10.6084/m9.figshare.26993353
title: Additional file 9 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 9: Table S8. Differentially expressed genes detected in Q175 vs WT sorted microglia.
DOI: 10.6084/m9.figshare.26993353.v1
title: Additional file 9 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 9: Table S8. Differentially expressed genes detected in Q175 vs WT sorted microglia.
DOI: 10.6084/m9.figshare.26993356
title: Additional file 10 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 10: Table S9. Pathway enrichment analysis for microglial datasets.
DOI: 10.6084/m9.figshare.26993356.v1
title: Additional file 10 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 10: Table S9. Pathway enrichment analysis for microglial datasets.
DOI: 10.6084/m9.figshare.26993359
title: Additional file 11 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 11: Table S10. Pathway enrichment analysis for microglial datasets integrated with downregulated pathways detected in Q175 vs Q175;Tyrobp(-/-).
DOI: 10.6084/m9.figshare.26993359.v1
title: Additional file 11 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 11: Table S10. Pathway enrichment analysis for microglial datasets integrated with downregulated pathways detected in Q175 vs Q175;Tyrobp(-/-).
DOI: 10.6084/m9.figshare.26993362
title: Additional file 12 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 12: Table S11. Isolation scheme of the DIA method.
DOI: 10.6084/m9.figshare.26993362.v1
title: Additional file 12 of TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

description: Additional file 12: Table S11. Isolation scheme of the DIA method.
DOI: 10.6084/m9.figshare.26993407
title: Additional file 6 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 6.
DOI: 10.6084/m9.figshare.26993407.v1
title: Additional file 6 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 6.
DOI: 10.6084/m9.figshare.26993413
title: Additional file 8 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 8.
DOI: 10.6084/m9.figshare.26993413.v1
title: Additional file 8 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 8.
DOI: 10.6084/m9.figshare.26993419
title: Additional file 10 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 10.
DOI: 10.6084/m9.figshare.26993419.v1
title: Additional file 10 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 10.
DOI: 10.6084/m9.figshare.26993425
title: Additional file 12 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 12.
DOI: 10.6084/m9.figshare.26993425.v1
title: Additional file 12 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 12.
DOI: 10.6084/m9.figshare.26993428
title: Additional file 13 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 13.
DOI: 10.6084/m9.figshare.26993428.v1
title: Additional file 13 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 13.
DOI: 10.6084/m9.figshare.26993431
title: Additional file 14 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 14.
DOI: 10.6084/m9.figshare.26993431.v1
title: Additional file 14 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 14.
DOI: 10.6084/m9.figshare.26993434
title: Additional file 15 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 15.
DOI: 10.6084/m9.figshare.26993434.v1
title: Additional file 15 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 15.
DOI: 10.6084/m9.figshare.26993440
title: Additional file 16 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 16.
DOI: 10.6084/m9.figshare.26993440.v1
title: Additional file 16 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 16.
DOI: 10.6084/m9.figshare.26993443
title: Additional file 17 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 17.
DOI: 10.6084/m9.figshare.26993443.v1
title: Additional file 17 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 17.
DOI: 10.6084/m9.figshare.26993446
title: Additional file 18 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 18.
DOI: 10.6084/m9.figshare.26993446.v1
title: Additional file 18 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 18.
DOI: 10.6084/m9.figshare.26993449
title: Additional file 19 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 19.
DOI: 10.6084/m9.figshare.26993449.v1
title: Additional file 19 of Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

description: Supplementary Material 19.
DOI: 10.15468/dl.dbscum
title: Occurrence Download

description: A dataset containing 15917 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is Datos de ocurrencia de triatominos presentes en Argentina del Laboratorio de Triatominos del CEPAVE (CONICET-UNLP)"
 ]
}

 The dataset includes 15917 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0011682-240906103802322/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.26993458
title: Additional file 3 of Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials

description: Additional file 3. The characteristics of the included studies.
DOI: 10.6084/m9.figshare.26993458.v1
title: Additional file 3 of Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials

description: Additional file 3. The characteristics of the included studies.
DOI: 10.6084/m9.figshare.26993497
title: Additional file 5 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 5. Detailed information on the characteristics of the included systematic reviews.
DOI: 10.6084/m9.figshare.26993521
title: Additional file 13 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 13. Effect sizes and forest plots on health impacts during the pandemic.
DOI: 10.6084/m9.figshare.26993521.v1
title: Additional file 13 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 13. Effect sizes and forest plots on health impacts during the pandemic.
DOI: 10.6084/m9.figshare.26993497.v1
title: Additional file 5 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 5. Detailed information on the characteristics of the included systematic reviews.
DOI: 10.6084/m9.figshare.26993500
title: Additional file 6 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 6. AMSTAR2 methodological quality assessments.
DOI: 10.6084/m9.figshare.26993500.v1
title: Additional file 6 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 6. AMSTAR2 methodological quality assessments.
DOI: 10.6084/m9.figshare.26993503
title: Additional file 7 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 7. Primary studies data extracted from single-armed meta-analyses of laboratory-confirmed COVID-19.
DOI: 10.6084/m9.figshare.26993503.v1
title: Additional file 7 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 7. Primary studies data extracted from single-armed meta-analyses of laboratory-confirmed COVID-19.
DOI: 10.6084/m9.figshare.26993509
title: Additional file 9 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 9. Effect sizes and forest plots on COVID-19-associated multisystem inflammatory syndrome.
DOI: 10.6084/m9.figshare.26993509.v1
title: Additional file 9 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 9. Effect sizes and forest plots on COVID-19-associated multisystem inflammatory syndrome.
DOI: 10.6084/m9.figshare.26993512
title: Additional file 10 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 10. Effect sizes and forest plots on newborns from COVID-19-diagnosed mothers.
DOI: 10.6084/m9.figshare.26993512.v1
title: Additional file 10 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 10. Effect sizes and forest plots on newborns from COVID-19-diagnosed mothers.
DOI: 10.6084/m9.figshare.26993515
title: Additional file 11 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 11. Effect sizes and forest plots on long-COVID.
DOI: 10.6084/m9.figshare.26993515.v1
title: Additional file 11 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 11. Effect sizes and forest plots on long-COVID.
DOI: 10.6084/m9.figshare.26993518
title: Additional file 12 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 12. Effect sizes and forest plots on events caused by the COVID-19 vaccine.
DOI: 10.6084/m9.figshare.26993518.v1
title: Additional file 12 of Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

description: Additional file 12. Effect sizes and forest plots on events caused by the COVID-19 vaccine.
DOI: 10.6084/m9.figshare.26993545
title: Additional file 3 of Landscape genomics reveals regions associated with adaptive phenotypic and genetic variation in Ethiopian indigenous chickens

description: Supplementary Material 3
DOI: 10.6084/m9.figshare.26993545.v1
title: Additional file 3 of Landscape genomics reveals regions associated with adaptive phenotypic and genetic variation in Ethiopian indigenous chickens

description: Supplementary Material 3
DOI: 10.6084/m9.figshare.26993548
title: Additional file 1 of Macrophages coordinate immune response to laser-induced injury via extracellular traps

description: Additional file 1. Raw data of RNA sequencing.
DOI: 10.6084/m9.figshare.26993548.v1
title: Additional file 1 of Macrophages coordinate immune response to laser-induced injury via extracellular traps

description: Additional file 1. Raw data of RNA sequencing.
DOI: 10.6084/m9.figshare.26993566
title: Additional file 1 of Molecular analysis of scats revealed diet and prey choice of grey wolves and Eurasian lynx in the contact zone between the Dinaric Mountains and the Alps

description: Additional file 1: Table S1. Study site and sample collection. Table S2. Details of PCR protocol. Table S3. Occurrence of prey taxa in wolf and lynx scats. Table S4. Relative read abundance (RRA) matrix (the proportion of identified reads assigned to each prey taxon for comparison analysis). Table S5. Prey taxa identity classification. Table S6. Results of DNA analysis of prey species presence in grey wolf and Eurasian lynx scats. Table S7. Frequency of occurrence of the important prey items in wolf and lynx diet. Table S8. Results of PERMANOVA, testing the effects of predator species and spatial variation on the changes of diet composition. Table S9. Prey taxa most responsible for driving differences in dietary composition between groups. Table S10. Results of the similarity percentage (SIMPER) analysis on interspecific and spatial dietary difference for wolf and lynx diet.
DOI: 10.6084/m9.figshare.26993566.v1
title: Additional file 1 of Molecular analysis of scats revealed diet and prey choice of grey wolves and Eurasian lynx in the contact zone between the Dinaric Mountains and the Alps

description: Additional file 1: Table S1. Study site and sample collection. Table S2. Details of PCR protocol. Table S3. Occurrence of prey taxa in wolf and lynx scats. Table S4. Relative read abundance (RRA) matrix (the proportion of identified reads assigned to each prey taxon for comparison analysis). Table S5. Prey taxa identity classification. Table S6. Results of DNA analysis of prey species presence in grey wolf and Eurasian lynx scats. Table S7. Frequency of occurrence of the important prey items in wolf and lynx diet. Table S8. Results of PERMANOVA, testing the effects of predator species and spatial variation on the changes of diet composition. Table S9. Prey taxa most responsible for driving differences in dietary composition between groups. Table S10. Results of the similarity percentage (SIMPER) analysis on interspecific and spatial dietary difference for wolf and lynx diet.
DOI: 10.6084/m9.figshare.26993572
title: Additional file 1 of Chromosome-level genome assembly provides insights into the genome evolution and functional importance of the phenylpropanoid–flavonoid pathway in Thymus mongolicus

description: Supplementary Material 1.
DOI: 10.6084/m9.figshare.26993572.v1
title: Additional file 1 of Chromosome-level genome assembly provides insights into the genome evolution and functional importance of the phenylpropanoid–flavonoid pathway in Thymus mongolicus

description: Supplementary Material 1.
DOI: 10.6084/m9.figshare.26993581
title: Additional file 2 of Vitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports

description: Supplementary Material 2.
DOI: 10.6084/m9.figshare.26993581.v1
title: Additional file 2 of Vitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports

description: Supplementary Material 2.
DOI: 10.6084/m9.figshare.26993596
title: Additional file 3 of Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis

description: Supplementary Material 3
DOI: 10.6084/m9.figshare.26993596.v1
title: Additional file 3 of Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis

description: Supplementary Material 3
DOI: 10.15468/dl.qh729q
title: Occurrence Download

description: A dataset containing 487 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Sladeniaceae"
 ]
}

 The dataset includes 487 records from 55 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0011683-240906103802322/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.cdmaf6
title: Occurrence Download

description: A dataset containing 71 species occurrences available in GBIF matching the query:
{
 "and" : [
 "GadmGid is DEU.15_1",
 "OccurrenceStatus is Present",
 "TaxonKey is Picea abies (L.) H.Karst.",
 "Year 1982-2014"
 ]
}

 The dataset includes 71 records from 23 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0078509-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.wcbjg7
title: Occurrence Download

description: A dataset containing 695 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Rana montezumae Baird, 1854"
 ]
}

 The dataset includes 695 records from 32 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0003616-150410134957023/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.